Skip to main content
Year archive

ENTROPY NEURODYNAMICS LIMITED — 2026 filings

All 34 regulatory filings released by ENTROPY NEURODYNAMICS LIMITED (ENP) in 2026, sourced directly from the official regulator.

34 Filings
2026 Period
2026 filings (34)
Filing Released Lang
Release of Securities from Escrow 3 pages 267.4KB
Share Issue/Capital Change
2026-05-21 English
Notification of cessation of securities - ENP 5 pages 16.3KB
Share Issue/Capital Change
2026-05-14 English
Change of Director's Interest Notice - JC 2 pages 5.9KB
Director's Dealing
2026-05-13 English
Australian Microcap Investment Conference presentation 21 pages 7.2MB
Investor Presentation
2026-05-10 English
Entropy files new US patent for IBS program 3 pages 287.9KB
Capital/Financing Update
2026-05-04 English
TRP 8802 delivers 75% breakthrough response in IBS 9 pages 815.3KB
Capital/Financing Update
2026-05-03 English
Quarterly Activities Report and Appendix 4C 13 pages 774.2KB
Interim / Quarterly Report
2026-04-27 English
Change of Director's Interest Notice - CN, DT, JC & HJ 8 pages 24.9KB
Director's Dealing
2026-04-19 English
Application for quotation of securities - ENP 8 pages 21.6KB
Share Issue/Capital Change
2026-04-16 English
Cleansing Notice 1 page 333.5KB
Capital/Financing Update
2026-04-16 English
TRP-8803 delivers repeatable, high-intensity effect 6 pages 460.7KB
Regulatory Filings
2026-04-13 English
Application for quotation of securities - ENP 8 pages 20.8KB
Share Issue/Capital Change
2026-04-13 English
Cleansing Notice 1 page 192.3KB
Capital/Financing Update
2026-04-13 English
Notification regarding unquoted securities - ENP 8 pages 23.6KB
Share Issue/Capital Change
2026-03-29 English
Results of EGM 3 pages 380.3KB
Declaration of Voting Results & Voting Rights Announcements
2026-03-18 English
Application for quotation of securities - ENP 8 pages 20.8KB
Share Issue/Capital Change
2026-03-12 English
Application for quotation of securities - ENP 8 pages 20.8KB
Share Issue/Capital Change
2026-03-09 English
Change of Director's Interest Notice - JC 3 pages 10.1KB
Director's Dealing
2026-03-09 English
FY25 R&D Tax Incentive received 2 pages 251.7KB
Capital/Financing Update
2026-03-04 English
Cohort 1 enrolment achieved for TRP-8803 BED Trial 3 pages 437.2KB
Regulatory Filings
2026-03-02 English
Application for quotation of securities - ENP 8 pages 20.8KB
Share Issue/Capital Change
2026-03-01 English
Appendix 4D and Half Year Report for period 31 Dec 2025 25 pages 530.0KB
Interim / Quarterly Report
2026-02-26 English
Update to Appendix 3B 2 pages 248.9KB
Capital/Financing Update
2026-02-15 English
Australian Patent Secures TRP 8803 Platform to 2042 5 pages 329.1KB
Regulatory Filings
2026-02-11 English
2026 EGM Letter of Access, Notice of Meeting and Proxy 19 pages 12.3MB
Proxy Solicitation & Information Statement
2026-02-08 English
Change of Director's Interest Notice - JC 3 pages 7.1KB
Director's Dealing
2026-02-05 English
Change of Director's Interest Notice - JC 3 pages 7.1KB
Director's Dealing
2026-02-03 English
Application for quotation of securities - ENP 8 pages 20.8KB
Share Issue/Capital Change
2026-02-01 English
Quarterly Activities Report and Appendix 4C 13 pages 666.6KB
Interim / Quarterly Report
2026-01-29 English
First TRP-8803 BED patient shows broad clinical improvement 6 pages 379.8KB
Regulatory Filings
2026-01-21 English
Application for quotation of securities - ENP 8 pages 21.6KB
Share Issue/Capital Change
2026-01-15 English
Cleansing Notice 1 page 209.7KB
Share Issue/Capital Change
2026-01-15 English
Change of Director's Interest Notice - HJ 2 pages 5.7KB
Director's Dealing
2026-01-15 English
TRP-8802 Phase 2a Trial Shows Sustained BED Reduction 7 pages 483.4KB
Regulatory Filings
2026-01-12 English